High‐Resolution Molecular‐Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2)
Chemistry – A European Journal · 04.04.2025 · 31 (20)
DOI: 10.1002/chem.202402534 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 15.03.2025. Verfasst von Quentin Delobelle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche Saint-Antoine - Team "Biologie et Thérapeutique du Cancer", UMRS 938 INSERM, Paris, France. Hauptthemen laut MEDLINE: Pyruvate Kinase, Membrane Proteins, Thyroid Hormones, Carrier Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council.
Abstract (Originalsprache)
Glucose metabolism plays a pivotal role in physiological processes and cancer growth. The final stage of glycolysis, converting phosphoenolpyruvate (PEP) into pyruvate, is catalyzed by the pyruvate kinase (PK) enzyme. Whereas PKM1 is mainly expressed in cells with high energy requirements, PKM2 is preferentially expressed in proliferating cells, including tumor cells. Structural analysis of PKM1 and PKM2 is essential to design new molecules with antitumoral activity. To understand their structural dynamics, we performed extensive high‐resolution molecular dynamics (MD) simulations using adaptive sampling techniques coupled to the polarizable AMOEBA force field. Performing more than 6 μs of simulation, we considered all oligomerization states of PKM2 and propose structural insights for PKM1 to further study the PKM2‐specific allostery. We focused on key sites including the active site and the natural substrate Fructose Bi‐Phosphate (FBP) fixation pocket. Additionally, we present the first MD simulation of biologically active PKM1 and uncover important similarities with its PKM2 counterpart bound to FBP. We also analysed TEPP‐46’s fixation, a pharmacological activator binding a different pocket, on PKM2 and highlighted the structural differences and similarities compared to PKM2 bound to FBP. Finally, we determined potential new cryptic pockets specific to PKM2 for drug targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de Recherche Saint-Antoine - Team "Biologie et Thérapeutique du Cancer", UMRS 938 INSERM, Paris, France.
- Sorbonne Université, CNRS, Laboratoire de Chimie Théorique, UMR 7616, 75005, Paris, France.
- University of California Berkeley, Bakar Institute of Digital Materials for the Planet, College of Computing, Data Science, and Society, Berkeley, 94720, USA.
- Sorbonne Université, CNRS, IPCM, 75005, Paris, France.
ORCID-Profile: Jean-Philip Piquemal
Förderung
- H2020 European Research Council
Zitieren
APA
Delobelle, Q., Inizan, T. J., Adjoua, O., Lagardère, L., Célerse, F., Maréchal, V., & Piquemal, J. P. (2025). High‐Resolution Molecular‐Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2). Chemistry – A European Journal, 31(20). https://doi.org/10.1002/chem.202402534
Vancouver
Delobelle Q, Inizan TJ, Adjoua O, Lagardère L, Célerse F, Maréchal V, et al. High‐Resolution Molecular‐Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2). Chemistry – A European Journal. 2025;31(20). doi:10.1002/chem.202402534
BibTeX
@article{Delobelle2025,
author = {Delobelle, Quentin and Inizan, Théo Jaffrelot and Adjoua, Olivier and Lagardère, Louis and Célerse, Frédéric and Maréchal, Vincent and Piquemal, Jean-Philip},
title = {High‐Resolution Molecular‐Dynamics Simulations of the Pyruvate Kinase Muscle Isoform 1 and 2 (PKM1/2)},
journal = {Chemistry – A European Journal},
year = {2025},
volume = {31},
number = {20},
doi = {10.1002/chem.202402534}
}
EUVIMED